Abstract

Metal stents (MS) are recommended for preoperative biliary drainage (PBD) in patients with periampullary cancer, but whether MS are superior in terms of re-intervention and direct cost is debatable. This study aimed to compare the effects of MS and PS on the outcomes of patients with periampullary cancer. For this random-effects meta-analysis, electronic databases were screened for randomized controlled trials (RCTs) published until January 2022. Subgroup analyses were performed basis on the center type and presence of NAC. In this meta-analysis, seven RCTs (440 participants) were included. MS reduced re-interventions (risk ratio [RR]=0.42, 95% confidence interval [CI]=0.25-0.72) and direct costs (mean difference=-474 USD, 95% CI=-656 to -292). PBD-related complications (RR=0.74, 95% CI=0.32-1.71) and postoperative complications (RR=0.73, 95% CI=0.45-1.17) did not differ between MS and PS. Compared PS, MS reduced postoperative complications in high-volume centers (RR=0.64, 95% CI=0.49-0.84) and PBD-related complications in patients receiving NAC (RR=0.29, 95% CI=0.08-1.08). Metal stents likely reduces re-interventions and direct costs. Further studies are needed to confirm the effects of MS on the outcomes.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call